Drug Shortage Report for BIO-HYDROCHLOROTHIAZIDE
Report ID | 18775 |
Drug Identification Number | 02247170 |
Brand name | BIO-HYDROCHLOROTHIAZIDE |
Common or Proper name | HYDROCHLOROTHIAZIDE |
Company Name | BIOMED PHARMA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C03AA |
ATC description | LOW-CEILING DIURETICS, THIAZIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-03-22 |
Actual start date | 2016-03-22 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-10-26 | French | Compare |
v3 | 2017-10-26 | English | Compare |
v2 | 2017-08-11 | French | Compare |
v1 | 2017-08-11 | English | Compare |
Showing 1 to 4 of 4